Data for: "Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink"

Harvard | Vancouver

Matthews, A, Langan, S, Douglas, I, Smeeth, L and Bhaskaran, K. Data for: "Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink". [Online]. London School of Hygiene & Tropical Medicine, London, United Kingdom. Available from: 10.17037/DATA.135

Export

Sharing

Study Description

Data associated with a PLOS Medicine publication that investigated whether PDE5 inhibitor use is associated with an increased risk of malignant melanoma, and whether any increase in risk is likely to represent a causal relationship.

Project start and completion date:
FromTo
20162016
Project contact: Matthews, Anthony
Associated roles: Matthews, Anthony, Langan, Sinead, Douglas, Ian J., Smeeth, Liam, Bhaskaran, Krishnan
LSHTM Faculty/Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Research Centre: Electronic Health Record Research Group
Participating Institutions: London School of Hygiene & Tropical Medicine

Documentation

No documents are available for this project

Data Collections

Actions

Edit Item Edit Item (admin only)